Rock Springs Capital Management LP Poseida Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

  • $3.22 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.87 - $5.0 $541,839 - $1.45 Million
-289,754 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$8.29 - $11.7 $644,506 - $909,616
-77,745 Reduced 21.16%
289,754 $3.18 Million
Q3 2020

Nov 16, 2020
BUY
$8.09 - $16.25 $2.97 Million - $5.97 Million
367,499 New
367,499 $3.26 Million

Others Institutions Holding PSTX

# of Institutions
95
Shares Held
38.1M
Call Options Held
417K
Put Options Held
42.7K
View Full List

About Poseida Therapeutics, Inc.

PSTX Quotes by TradingView
  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $249M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email